HRP20090015T3 - Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition - Google Patents

Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Info

Publication number
HRP20090015T3
HRP20090015T3 HR20090015T HRP20090015T HRP20090015T3 HR P20090015 T3 HRP20090015 T3 HR P20090015T3 HR 20090015 T HR20090015 T HR 20090015T HR P20090015 T HRP20090015 T HR P20090015T HR P20090015 T3 HRP20090015 T3 HR P20090015T3
Authority
HR
Croatia
Prior art keywords
combination
serotonin reuptake
alkyl
reuptake inhibition
receptor agonism
Prior art date
Application number
HR20090015T
Other languages
English (en)
Croatian (hr)
Inventor
W. Feenstra Roelof
Stoit Axel
Terpstra Jan-Willem
L. Pras-Raves Maria
C. Mccreary Andrew
J. Van Vliet Bernard
B. Hesselink Mayke
G. Kruse Cornelis
Van Scharrenburg G.J.M.
Original Assignee
Solvay Pharmaceuticals B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals B.V. filed Critical Solvay Pharmaceuticals B.V.
Publication of HRP20090015T3 publication Critical patent/HRP20090015T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20090015T 2004-12-08 2005-12-06 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition HRP20090015T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63407404P 2004-12-08 2004-12-08
EP04106394 2004-12-08
PCT/EP2005/056507 WO2006061378A1 (en) 2004-12-08 2005-12-06 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Publications (1)

Publication Number Publication Date
HRP20090015T3 true HRP20090015T3 (en) 2009-02-28

Family

ID=35744728

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20090015T HRP20090015T3 (en) 2004-12-08 2005-12-06 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
HR20080538T HRP20080538T3 (en) 2004-12-08 2005-12-06 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20080538T HRP20080538T3 (en) 2004-12-08 2005-12-06 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Country Status (18)

Country Link
EP (4) EP1827427B1 (enExample)
JP (4) JP2008523031A (enExample)
KR (4) KR20070085959A (enExample)
AT (2) ATE401883T1 (enExample)
AU (4) AU2005313390A1 (enExample)
BR (1) BRPI0518613A2 (enExample)
CA (4) CA2587202A1 (enExample)
DE (2) DE602005008471D1 (enExample)
DK (2) DK1824479T3 (enExample)
ES (2) ES2311245T3 (enExample)
HR (2) HRP20090015T3 (enExample)
IL (4) IL183061A0 (enExample)
NO (4) NO20072981L (enExample)
PL (2) PL1827427T3 (enExample)
PT (2) PT1824479E (enExample)
RU (4) RU2007125660A (enExample)
SI (2) SI1824479T1 (enExample)
WO (4) WO2006061377A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059227A1 (es) * 2006-01-30 2008-03-19 Speedel Experimenta Ag Proceso para la preparacion de compuestos organicos
US8063062B2 (en) 2006-12-20 2011-11-22 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
US8138174B2 (en) 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition
CA2671554A1 (en) * 2007-01-10 2008-07-17 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
JP2010525013A (ja) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン２受容体アンタゴニストとしてのピリジン誘導体
WO2008128996A1 (en) * 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
KR20100016620A (ko) * 2007-04-23 2010-02-12 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 4-알콕시피리다진 유도체
CN103360342B (zh) * 2012-04-09 2015-12-16 江苏恩华药业股份有限公司 3-氰基苯胺烷基芳基哌嗪衍生物及在制备药物中的应用
CN103570698B (zh) * 2012-08-01 2016-08-03 江苏恩华药业股份有限公司 用于制备维拉佐酮的化合物及其中间体和应用
ITMI20130392A1 (it) * 2013-03-15 2014-09-16 Dipharma Francis Srl Sintesi di un inibitore della ricaptazione della serotonina
EP3010586A1 (en) 2013-06-21 2016-04-27 Lupin Limited Substituted heterocyclic compounds as crac modulators
US9790231B2 (en) 2013-06-24 2017-10-17 Lupin Limited Chromane and chromene derivatives and their use as CRAC modulators
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
CN1304403A (zh) * 1998-04-08 2001-07-18 美国家用产品公司 用于治疗抑郁症的n－芳氧基乙基－吲哚基－烷基胺(5－ht1a受体活化剂)
CA2335711A1 (en) * 1998-06-19 1999-12-29 Ivan Mikkelsen 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
WO2001014330A2 (en) * 1999-08-23 2001-03-01 Solvay Pharmaceuticals B.V. Phenylpiperazines as serotonin reuptake inhibitors
CN1723209A (zh) * 2002-12-10 2006-01-18 默克专利有限公司 吲哚衍生物以及它们作为5－ht配体的应用

Also Published As

Publication number Publication date
WO2006061378A1 (en) 2006-06-15
JP2008523029A (ja) 2008-07-03
CA2587202A1 (en) 2006-06-15
IL183061A0 (en) 2007-09-20
CA2587357A1 (en) 2006-06-15
NO20072974L (no) 2007-08-23
DK1824479T3 (da) 2009-03-09
WO2006061377A1 (en) 2006-06-15
EP1824479B1 (en) 2008-11-05
KR20070085975A (ko) 2007-08-27
ATE401883T1 (de) 2008-08-15
JP2008537725A (ja) 2008-09-25
IL183064A0 (en) 2007-09-20
DE602005008471D1 (de) 2008-09-04
NO20072981L (no) 2007-09-05
BRPI0518613A2 (pt) 2008-11-25
CA2587381A1 (en) 2006-06-15
RU2007125661A (ru) 2009-01-20
KR20070085959A (ko) 2007-08-27
JP2008523031A (ja) 2008-07-03
PT1824479E (pt) 2009-01-30
DE602005010902D1 (de) 2008-12-18
EP1827426A1 (en) 2007-09-05
AU2005313390A1 (en) 2006-06-15
KR20070085988A (ko) 2007-08-27
AU2005313312A1 (en) 2006-06-15
ES2317335T3 (es) 2009-04-16
DK1827427T3 (da) 2008-11-24
HRP20080538T3 (en) 2008-12-31
IL183062A0 (en) 2007-09-20
NO20072969L (no) 2007-08-31
SI1824479T1 (sl) 2009-04-30
RU2007125658A (ru) 2009-01-20
WO2006061379A1 (en) 2006-06-15
EP1824480A1 (en) 2007-08-29
NO20072977L (no) 2007-09-05
CA2587559A1 (en) 2006-06-15
RU2007125659A (ru) 2009-01-20
PL1827427T3 (pl) 2009-01-30
ES2311245T3 (es) 2009-02-01
SI1827427T1 (sl) 2008-12-31
WO2006061376A1 (en) 2006-06-15
EP1827427A1 (en) 2007-09-05
IL183063A0 (en) 2007-09-20
EP1827427B1 (en) 2008-07-23
AU2005313311A1 (en) 2006-06-15
KR20070085916A (ko) 2007-08-27
ATE413173T1 (de) 2008-11-15
JP2008523030A (ja) 2008-07-03
EP1824479A1 (en) 2007-08-29
PL1824479T3 (pl) 2009-04-30
PT1827427E (pt) 2008-11-03
RU2007125660A (ru) 2009-01-20
AU2005313391A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
HRP20090015T3 (en) Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
HRP20030003B1 (en) N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
NO20074057L (no) 2,4-Diaminopyridopyrimidinderivater og deres anvendelse som mTOR-inhibitorer
DK0862567T3 (da) 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
HRP20020175B1 (hr) N-heterociklički derivati kao inhibitori nos
NO20022317L (no) Trifenylalkylen-derivater og deres anvendelse som selektive östrogen-reseptor-modulater
NO20080323L (no) Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer og deres anvendlse innen medisinen
NO20080325L (no) Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer samt deres anvendelse innen medisin
WO2008136444A1 (ja) 縮合複素環誘導体
HRP20070529T3 (hr) Derivati imidazola kao antagonisti receptora glutamata
IN2009KN04279A (enExample)
EP1854789A4 (en) QUINAZOLINE DERIVATIVE HAVING TYROSINE KINASE INHIBITORY ACTIVITY
TW200517387A (en) Compounds exhibiting thrombopoietin receptor agonism
DK1763534T3 (da) Nye 2-substituerede D-homo-estra-1,3,5(10)-triener som inhibitorer af 17beta-hydroxysteroiddehydrogenasen type 1
PL1692098T3 (pl) Pochodna alfa-ketomidu oraz sposób jej wytwarzania i zastosowanie
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20110780T1 (hr) Aminoarilsulfonamidni spojevi i njihova upotreba kao ligandi 5-ht6
HRP20030381B1 (en) 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
HRP20090143T3 (hr) N-oksidi kao predlijekovi derivata piperazina i piperidina
TW200704633A (en) Process for the preparation of sulfonamide derivatives
HRP20080363T3 (hr) Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora
TW200700419A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
BRPI0400141A (pt) Composição de incenso inseticida, e emulsão e processo para produção da mesma